Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Discovery collaboration underway with Center for Cellular Immunotherapies Lab at University of Pennsylvania to Study Combinations of Novel Viral Immunotherapy and CAR-T Cell Therapy Candidates in Solid
Source: finanznachrichten.de